Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study
Shim, J., Kim, K., Kim, K. G., Choi, U., Kyung, J. W., Sohn, S., Lim, S. H., Choi, H., Ahn, T., Choi, H. J., Shin, D. and Han, I. Safety and efficacy of Wharton’s jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study. STEM CELLS Translational Medicine. 2020. doi: 10.1002/sctm.20-0308
Read More